Table 1 Evaluation of tumour CCND1 amplification in high plasma CCND1/DRD2 ratio group

From: Prediction of CCND1 amplification using plasma DNA as a prognostic marker in oesophageal squamous cell carcinoma

  

Tumour CCND1

 

Number

Amplification

Non-amplification

High plasma CCND1/ DRD2 ratio group

19

14 (74%)

5 (26%)

  1. Abbreviations: CCND1=cyclin D1; DRD2=dopamine receptor D2.
Back to article page